Popular
-
UNIST Signs MoU with Aramco Korea and MIDAM to..
Apr 29, 2021 -
UNIST and Ulsan to Announce Successful Complet..
Apr 27, 2021 -
Understanding Graphene Growth on Insulating Su..
Apr 23, 2021
TonEBP Promotes Metabolic Diseases … “From Basic Research to New Drug Development”
Professor Hyug Moo Kwon (School of Life Sciences, UNIST) has published a review paper at 'Nature Review Nephrology'.
“This paper summarizes the nine years of my research that has been underway since joining UNIST. It starts with a study on the role of TonEBP* protein and clarifies its connection with metabolic diseases. We hope these achievements wi... Read More
UNIST Researcher Recognized with 2018 Merck Life Science Awards
Jun Ho Lee, a doctroral student in Life Sciences at UNIST, named a recipient of 2018 Life Science Awards.
Jun Ho Lee, a doctroral student in Life Sciences at UNIST, has been named as a recipient of Merck’s 2018 Life Science Awards in Tumor Biology, receiving the grand prize of $10,000. This award has been given to Jun Ho Lee in recognitio... Read More
UNIST to Accelerate New Treatments Against Incurable Diseases
On August 23, UNIST held a grand opening ceremony of Cellular Responses to Metabolic Stress Research Center.
On August 23, UNIST held a grand opening ceremony of Cellular Responses to Metabolic Stress Research Center (CRMSRC) in a bid to accelerate the discovery and development of breakthrough medicines for diseases thought to be incurable. Follow... Read More
UNIST-Ulsan Develop Organs-on-chips for New Drug Discovery
UNIST-WRIRM-UniBasel Organ Mimetic Research Center has secured KRW 3.9 billion for the next 6 years.
UNIST and Ulsan will initiate a research collaboration to develop human organs-on-chips in hoping to reduce the time and cost for new drug discovery. The UNIST-WRIRM-UniBasel Organ Mimetic Research Center has announced that it has been sele... Read More
Groundbreaking Study Sheds Light on Treating Liver Cancer
Their findings published in the prestigious BMJ, a leading international journal in gastroenterology and hepatology.
Liver cancer resists most chemotherapy drugs. Even if cancer cells are completely removed, the recurrence rate in patients who have undergone complete surgical resection reaches up to 70%. Despite medical advancements, treating liver cancer... Read More
